$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Net Receivables
$166.00M
Quarterly · Period ending: · USD

RARE Net Receivables
Latest reported$159.00Mperiod ending
Latest reported$159.00Mperiod ending
RARE FY Net Receivables ($103.00K → $159.00M)
Annual net receivables
High-resolution chart · PNG
What is net receivables?
Net amount expected from customer receivables.
RARE net receivables history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 159,000,000 | |
| 121,801,000 | |
| 73,390,000 | |
| 40,445,000 | |
| 44,432,000 | |
| 23,093,000 | |
| 32,844,000 | |
| 12,740,000 | |
| 5,172,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 103,000 |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance